Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Share-based Compensation (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Share-based Compensation came in at $95.0 million in Q2 2026, up 58.33% year-over-year from $60.0 million in Q2 2025, and up 46.15% quarter-over-quarter from $65.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Share-based Compensation (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Share-based Compensation across 15 years of filings, most recently posting $95.0 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 58.33% year-over-year to $95.0 million; the TTM figure through Jun 2026 stood at $275.0 million (up 17.52% YoY), while the FY2025 annual figure was $247.0 million, up 19.9% from the prior year.
  • Share-based Compensation came in at $95.0 million for Q2 2026 at Iqvia Holdings, up from $65.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $95.0 million in Q2 2026 to a low of $30.0 million in Q1 2022.
  • Average Share-based Compensation over 5 years is $56.9 million, with a median of $55.5 million recorded in 2024.
  • Year-over-year, Share-based Compensation jumped 150.0% in 2023 and slipped 25.33% in 2024.
  • Over 5 years, Share-based Compensation stood at $58.0 million in 2022, then fell by 22.41% to $45.0 million in 2023, then rose by 6.67% to $48.0 million in 2024, then gained by 25.0% to $60.0 million in 2025, then jumped by 58.33% to $95.0 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $95.0 million in Q2 2026, $65.0 million in Q1 2026, and $60.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 95.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 4.35 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 18.46 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 19.78 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 12.60 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 7.60 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 6.25 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 530,728.82
10 VivoSim Labs 1.37 Mn 1.37 Mn - 91,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.00 Mn
Mar 31, 2026 65.00 Mn
Dec 31, 2025 60.00 Mn
Sep 30, 2025 55.00 Mn
Jun 30, 2025 60.00 Mn
Mar 31, 2025 72.00 Mn
Dec 31, 2024 48.00 Mn
Sep 30, 2024 54.00 Mn
Jun 30, 2024 48.00 Mn
Mar 31, 2024 56.00 Mn
Dec 31, 2023 45.00 Mn
Sep 30, 2023 47.00 Mn
Jun 30, 2023 50.00 Mn
Mar 31, 2023 75.00 Mn
Dec 31, 2022 58.00 Mn
Sep 30, 2022 61.00 Mn
Jun 30, 2022 45.00 Mn
Mar 31, 2022 30.00 Mn
Dec 31, 2021 42.00 Mn
Sep 30, 2021 48.00 Mn